Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.
Tisseur L, Cojean S, Gassama K, Logé C, Pagniez F, Cavé C, Bernadat G, Loiseau PM, Bach S, Thiéfaine J, Picot C, Tomasoni C, Leclercq O, Baratte B, Robert T, Le Pape P, Rachidi N, Bazin MA, Marchand P. Tisseur L, et al. Among authors: le pape p. ChemMedChem. 2024 Dec 17:e202400862. doi: 10.1002/cmdc.202400862. Online ahead of print. ChemMedChem. 2024. PMID: 39688580
Early Restrictive vs Liberal Oxygen for Trauma Patients: The TRAUMOX2 Randomized Clinical Trial.
Arleth T, Baekgaard J, Siersma V, Creutzburg A, Dinesen F, Rosenkrantz O, Heiberg J, Isbye D, Mikkelsen S, Hansen PM, Zwisler ST, Darling S, Petersen LB, Mørkeberg MCR, Andersen M, Fenger-Eriksen C, Bach PT, Van Vledder MG, Van Lieshout EMM, Ottenhof NA, Maissan IM, Den Hartog D, Hautz WE, Jakob DA, Iten M, Haenggi M, Albrecht R, Hinkelbein J, Klimek M, Rasmussen LS, Steinmetz J; TRAUMOX2 Trial Group. Arleth T, et al. JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.25786. Online ahead of print. JAMA. 2024. PMID: 39657224
Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
Gaborit B, Lécuyer R, Issa N, Camou F, Lavergne RA, Gabriel F, Morio F, Canet E, Raffi F, Boutoille D, Cady A, Gousseff M, Crabol Y, Néel A, Tessoulin B; Prognostic Factors in Pneumocystis Pneumoniae (PRONOCYSTIS) Study Group. Gaborit B, et al. Chest. 2024 Oct;166(4):708-711. doi: 10.1016/j.chest.2024.04.038. Epub 2024 Jun 10. Chest. 2024. PMID: 38866071 Free article. No abstract available.
Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.
Hartuis S, Ourliac-Garnier I, Robert E, Albassier M, Duchesne L, Beaufils C, Kuhn J, Le Pape P, Morio F. Hartuis S, et al. Among authors: le pape p. Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0002224. doi: 10.1128/aac.00022-24. Epub 2024 Apr 16. Antimicrob Agents Chemother. 2024. PMID: 38624217 Free PMC article.
Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
Lécuyer R, Issa N, Camou F, Lavergne RA, Gabriel F, Morio F, Canet E, Raffi F, Boutoille D, Cady A, Gousseff M, Crabol Y, Néel A, Tessoulin B, Gaborit B; PRONOCYSTIS Study Group. Lécuyer R, et al. Chest. 2024 Jun;165(6):1319-1329. doi: 10.1016/j.chest.2024.01.015. Epub 2024 Jan 11. Chest. 2024. PMID: 38215935 Free article.
204 results